A

Anthem Biosciences Limited

ANTHEMNSE
Market snapshot · 2026-08-12 03:38 UTC

MARKET CAP

STOCK P/E

52W HIGH

52W LOW

BOOK VALUE

EPS

ROE

SECTOR

Health Care

DEBT/EQUITY

VOLUME

P/B RATIO

PEG RATIO

Sector

Health Care

Themes

Biotechnology

Loading chart…

AI Summary

✦ Clartha

Valuation Metrics

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

Historical valuation metrics are unavailable for this ticker right now.

Peers & Comparison

Sector: Health Care · Theme: Biotechnology

Biotechnology Peers8 peers
CompanyRev. GrowthMarginP/Evs Avg52W Perf.
BIOCON
BIOCONBiotechnology
ACUTAAS
ACUTAASBiotechnology
HESTERBIO
HESTERBIOBiotechnology
ONESOURCE
ONESOURCEBiotechnology
PANACEABIO
PANACEABIOBiotechnology
SAILIFE
SAILIFEBiotechnology
BIOGEN PHARMACHEM INDUSTRIES LTD
BIOGEN PHARMACHEM INDUSTRIES LTDBiotechnology
SHEEL
SHEELBiotechnology
WHY THESE PEERS

Anthem Biosciences Limited is compared against the Biotechnology cohort. Peers include BIOCON, ACUTAAS, HESTERBIO — selected based on business model, industry classification, market cap similarity, and business theme alignment.

Financials

Financial chart data is not available for this company right now.

Results

Income statement data not available.

All values in ₹ Crores unless otherwise stated. Source: Company filings.

Shareholding Pattern

HolderMar 2023Mar 2024Sep 2025Dec 2025Mar 2026
Promoters76.84%76.70%74.69%74.69%74.68%
FII1.66%1.37%1.28%
DII7.21%7.60%11.55%
Public11.07%11.05%9.61%9.60%9.37%
Others12.09%12.25%6.83%6.74%3.12%
Mar 2026
Promoters
FII
DII
Public
Others

Events Timeline

Concall Transcript - FY2027

Jul 27, 2026PDFKnowledge Base Open

Concall Transcript - FY2027

Jul 22, 2026PDFKnowledge Base Open

Concall Transcript - FY2027

Jul 15, 2026PDFKnowledge Base Open

Financial Results - FY2027

Jul 02, 2026PDFKnowledge Base Open

Concall Transcript - FY2027

Jun 05, 2026PDFKnowledge Base Open